🚨 NEW COMMENT ⚕️💡
Calvert et al. summarise evidence on the value of patient-reported outcomes throughout the drug development pipeline and provide a summary of guidance documents to support optimal assessment in drug development.
Calvert et al. highlight how patient-reported outcomes (PROs) provide critical evidence for drug regulation, reimbursement, and clinical care. They advocate for using international guidelines and tools to enhance data quality and maximize the impact of these data to support decision-making and patient-centred care.
